These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10471523)

  • 21. Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms.
    Perry A; Kunz SN; Fuller CE; Banerjee R; Marley EF; Liapis H; Watson MA; Gutmann DH
    J Neuropathol Exp Neurol; 2002 Aug; 61(8):702-9. PubMed ID: 12152785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TP53 mutation analysis of malignant peripheral nerve sheath tumors.
    Verdijk RM; den Bakker MA; Dubbink HJ; Hop WC; Dinjens WN; Kros JM
    J Neuropathol Exp Neurol; 2010 Jan; 69(1):16-26. PubMed ID: 20010306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of Y chromosome in the malignant peripheral nerve sheet tumor of a patient with Neurofibromatosis type 1.
    Jeong SY; Park SJ; Lee SJ; Park HJ; Kim HJ
    J Korean Med Sci; 2010 May; 25(5):804-8. PubMed ID: 20436723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours.
    Bottillo I; Ahlquist T; Brekke H; Danielsen SA; van den Berg E; Mertens F; Lothe RA; Dallapiccola B
    J Pathol; 2009 Apr; 217(5):693-701. PubMed ID: 19142971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells.
    Fischer-Huchzermeyer S; Dombrowski A; Hagel C; Mautner VF; Schittenhelm J; Harder A
    Am J Pathol; 2017 Jul; 187(7):1623-1632. PubMed ID: 28502478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho-GTPase pathway genes in NF1 tumorigenesis.
    Upadhyaya M; Spurlock G; Thomas L; Thomas NS; Richards M; Mautner VF; Cooper DN; Guha A; Yan J
    Hum Mutat; 2012 Apr; 33(4):763-76. PubMed ID: 22331697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of Treatment for Malignant Peripheral Nerve Sheath Tumors: Different Clinical Features Associated with Neurofibromatosis Type 1.
    Hwang IK; Hahn SM; Kim HS; Kim SK; Kim HS; Shin KH; Suh CO; Lyu CJ; Han JW
    Cancer Res Treat; 2017 Jul; 49(3):717-726. PubMed ID: 28052660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors.
    Birindelli S; Perrone F; Oggionni M; Lavarino C; Pasini B; Vergani B; Ranzani GN; Pierotti MA; Pilotti S
    Lab Invest; 2001 Jun; 81(6):833-44. PubMed ID: 11406645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors.
    Hagel C; Zils U; Peiper M; Kluwe L; Gotthard S; Friedrich RE; Zurakowski D; von Deimling A; Mautner VF
    J Neurooncol; 2007 Apr; 82(2):187-92. PubMed ID: 17111191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adhesion molecule L1 is down-regulated in malignant peripheral nerve sheath tumors versus benign neurofibromatosis type 1-associated tumors.
    Blessmann M; Gröbe A; Quaas A; Kaifi JT; Mistakidis G; Bernreuther C; Sauter G; Gros S; Rawnaq T; Friedrich R; Mautner VF; Smeets R; Heiland M; Schachner M; Izbicki JR
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):239-44. PubMed ID: 22677742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.
    Endo M; Yamamoto H; Setsu N; Kohashi K; Takahashi Y; Ishii T; Iida K; Matsumoto Y; Hakozaki M; Aoki M; Iwasaki H; Dobashi Y; Nishiyama K; Iwamoto Y; Oda Y
    Clin Cancer Res; 2013 Jan; 19(2):450-61. PubMed ID: 23209032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromosomal aberrations and microsatellite instability of malignant peripheral nerve sheath tumors: a study of 10 tumors from nine patients.
    Kobayashi C; Oda Y; Takahira T; Izumi T; Kawaguchi K; Yamamoto H; Tamiya S; Yamada T; Oda S; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
    Cancer Genet Cytogenet; 2006 Mar; 165(2):98-105. PubMed ID: 16527603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms.
    Longo JF; Weber SM; Turner-Ivey BP; Carroll SL
    Adv Anat Pathol; 2018 Sep; 25(5):353-368. PubMed ID: 29762158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis.
    Woodruff JM
    Am J Med Genet; 1999 Mar; 89(1):23-30. PubMed ID: 10469433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival.
    Cleven AH; Sannaa GA; Briaire-de Bruijn I; Ingram DR; van de Rijn M; Rubin BP; de Vries MW; Watson KL; Torres KE; Wang WL; van Duinen SG; Hogendoorn PC; Lazar AJ; Bovée JV
    Mod Pathol; 2016 Jun; 29(6):582-90. PubMed ID: 26990975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation-Induced Glandular Malignant Peripheral Nerve Sheath Tumor.
    John I; Bartlett DL; Rao UNM
    Int J Surg Pathol; 2017 Oct; 25(7):635-639. PubMed ID: 28530162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The heterogeneous nature of germline mutations in NF1 patients with malignant peripheral serve sheath tumours (MPNSTs).
    Upadhyaya M; Spurlock G; Majounie E; Griffiths S; Forrester N; Baser M; Huson SM; Gareth Evans D; Ferner R
    Hum Mutat; 2006 Jul; 27(7):716. PubMed ID: 16786508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients.
    Frahm S; Mautner VF; Brems H; Legius E; Debiec-Rychter M; Friedrich RE; Knöfel WT; Peiper M; Kluwe L
    Neurobiol Dis; 2004 Jun; 16(1):85-91. PubMed ID: 15207265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression patterns of cell cycle components in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.
    Agesen TH; Flørenes VA; Molenaar WM; Lind GE; Berner JM; Plaat BE; Komdeur R; Myklebost O; van den Berg E; Lothe RA
    J Neuropathol Exp Neurol; 2005 Jan; 64(1):74-81. PubMed ID: 15715087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurofibroma and schwannoma.
    Ferner RE; O'Doherty MJ
    Curr Opin Neurol; 2002 Dec; 15(6):679-84. PubMed ID: 12447105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.